Advance ZincTek Limited (ANO) AI Stock Analysis

• Market Cap: AU$59.51M
• Dividend Yield: N/A
• Average Volume (3M): 3.07K
• Price to Earnings (P/E): 48.0
• Beta (1Y): 0.72
• Revenue Growth: 24.88%
• EPS Growth: N/A
• Country: AU
• Employees: 25
• Sector: Basic Materials
• Sector Strength: 58
• Industry: Chemicals
• EPS (TTM): <0.01
• Shares Outstanding: 62,646,107
• 10 Day Avg. Volume: 7,300
• 30 Day Avg. Volume: 3,070
• PEG Ratio: -0.17
• Price to Book (P/B): 1.35
• Price to Sales (P/S): 3.98
• P/FCF Ratio: 27.10
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: AU$1.00
• Price Target Upside: 5.26% Upside
• Rating Consensus: Hold
• Number of Analyst Covering: 1

• Rating: 59 Neutral
• Price Target: AU$1.00 ▲(5.26% Upside)

Advance ZincTek Limited's overall stock score is driven by solid financial performance, characterized by strong revenue growth and financial stability. However, technical analysis indicates mixed signals with bearish momentum, and the high P/E ratio suggests potential overvaluation. The absence of a dividend yield further impacts the valuation score.

Advance ZincTek Limited Business Overview & Revenue Model

Company Description

Advance ZincTek Limited (ANO) is an Australian company specializing in the manufacturing and distribution of zinc oxide-based products. Operating primarily within the personal care and cosmetics sectors, the company is renowned for its innovative formulations that provide superior sun protection and skincare benefits. Its core products include high-quality zinc oxides used in sunscreens, skincare products, and other cosmetic applications, catering to both domestic and international markets.

How the Company Makes Money

Advance ZincTek Limited generates revenue through the production and sale of its zinc oxide products. The company primarily earns money by supplying these products to manufacturers in the personal care and cosmetics industries, who incorporate them into sunscreens, lotions, and other skincare solutions. Key revenue streams include direct sales to major beauty and skincare brands, as well as distribution through partnerships with suppliers and distributors that reach a global customer base. The company's focus on high-quality, safe, and effective ingredients contributes to its competitive positioning and demand for its products.

Advance ZincTek Limited Financial Statement Overview

Summary

Advance ZincTek Limited demonstrates solid financial performance with strong revenue growth and improved profitability margins. The balance sheet reflects financial stability with low leverage, while cash flow metrics indicate healthy cash generation. Continued focus on enhancing net profit margins and return on equity could further strengthen the company's financial position.

Income Statement

Advance ZincTek Limited shows a strong revenue growth rate of 20.4% in the latest year, recovering from a previous decline. The gross profit margin improved significantly to 58.8%, indicating better cost management. However, the net profit margin is relatively low at 10.2%, suggesting room for improvement in profitability. The EBIT and EBITDA margins are healthy, reflecting efficient operations.

Balance Sheet

The company maintains a low debt-to-equity ratio of 0.039, indicating conservative leverage and financial stability. Return on equity is modest at 3.5%, suggesting moderate efficiency in generating returns from equity. The equity ratio is strong, highlighting a solid capital structure.

Cash Flow

Free cash flow growth is impressive at 66.8%, showing improved cash generation capabilities. The operating cash flow to net income ratio is robust at 2.21, indicating strong cash flow relative to earnings. The free cash flow to net income ratio of 0.67 suggests good cash conversion, though there is potential for further enhancement.

Breakdown	TTM	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Income Statement
Total Revenue	12.17M	12.17M	9.32M	13.74M	12.50M	6.52M
Gross Profit	7.16M	7.16M	846.00K	3.62M	3.91M	1.57M
EBITDA	3.14M	3.14M	252.00K	3.82M	5.10M	1.33M
Net Income	1.24M	1.24M	-903.00K	1.66M	2.19M	32.00K
Balance Sheet
Total Assets	38.04M	38.04M	37.74M	39.06M	38.36M	34.46M
Cash, Cash Equivalents and Short-Term Investments	629.00K	629.00K	163.00K	325.00K	1.33M	95.00K
Total Debt	1.40M	1.40M	1.99M	2.18M	2.54M	3.04M
Total Liabilities	2.27M	2.27M	3.36M	3.78M	3.37M	6.51M
Stockholders Equity	35.77M	35.77M	34.38M	35.28M	34.99M	27.96M
Cash Flow
Free Cash Flow	1.79M	1.79M	31.00K	1.61M	-1.59M	-2.65M
Operating Cash Flow	2.67M	2.67M	2.24M	4.42M	1.62M	1.39M
Investing Cash Flow	-1.42M	-1.42M	-2.21M	-3.49M	-2.17M	-4.04M
Financing Cash Flow	-786.00K	-786.00K	-193.00K	-1.93M	1.78M	2.48M

Advance ZincTek Limited Technical Analysis

• Technical Analysis Sentiment: Neutral
• Last Price: 0.95
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Positive
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AU:ANO, the sentiment is Neutral. The current price of 0.95 is above the 20-day moving average (MA) of 0.94, below the 50-day MA of 1.06, and above the 200-day MA of 0.86, indicating a neutral trend. The MACD of -0.03 indicates Negative momentum. The RSI at 42.98 is Neutral, neither overbought nor oversold. The STOCH value of 80.00 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for AU:ANO.

Advance ZincTek Limited Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
Sector *	61 Neutral	$10.43B	7.12	-0.05%	2.87%	2.86%	-36.73%
ANO	59 Neutral	AU$59.51M	47.98	3.53%	―	24.88%	―
HZR	48 Neutral	AU$133.50M	―	-55.86%	―	―	64.63%
ATC	44 Neutral	AU$101.40M	―	-39.14%	―	―	57.49%
LEL	39 Underperform	AU$41.44M	―	-13.86%	―	―	-12.34%
BKT	32 Underperform	AU$44.04M	―	-15.13%	―	―	23.60%

Advance ZincTek Limited Corporate Events

Advance ZincTek Addresses ASX Price Query Amid Unexplained Share Activity

Advance ZincTek Limited (ANO) has responded to an ASX price query regarding unusual trading activity in its securities. The company stated that it is unaware of any undisclosed information that could explain the recent increase in share price and confirmed compliance with ASX Listing Rules. ANO emphasized that no trading has involved directors or officers due to a blackout period, and the response was approved by the board.

Advance ZincTek Limited Unaffected by New U.S. Tariffs

Advance ZincTek Limited (ANO) is currently unaffected by the new 200% tariffs imposed by the Trump Administration on Australian pharmaceutical companies, as zinc oxide remains exempt. ANO is considering the possibility of relocating to the USA if necessary, given its automated processes and ability to control equipment from Australia. The company does not anticipate any negative impact on its U.S. business, while its competitors in Japan and South Korea face significant tariffs.

Advance ZincTek Limited Reports $2.7 Million Profit Turnaround

Advance ZincTek Limited has reported a significant financial turnaround, with sales revenue for FY25 reaching $11.4 million, surpassing the previous year’s total. This growth is attributed to increased sales in the USA and operational efficiencies following the closure of its Perth facilities. The company anticipates a profit before tax of approximately $1.95 million, a notable improvement from the prior year’s loss. With a strong balance sheet, including cash reserves of $525,305 and no debt, the company is exploring capital management initiatives to be discussed at the upcoming Annual General Meeting.

Advance ZincTek Limited Issues New Securities to Boost Employee Incentives

Advance ZincTek Limited has announced the issuance of 36,344 fully paid ordinary securities on June 27, 2025, as part of an employee incentive scheme. This move is expected to enhance the company’s operational capabilities by aligning employee interests with corporate goals, potentially strengthening its market position and benefiting stakeholders.

Advance ZincTek Director’s Interest Update

Advance ZincTek Limited has announced a change in the director’s interest, specifically concerning Lev Mizikovsky. The director acquired 5,165 ordinary shares through an on-market trade, increasing his direct holdings to 165,361 shares, while his indirect holdings remain unchanged at 40,243,902 shares. This change reflects a minor adjustment in the director’s investment, with no significant implications for the company’s overall operations or market positioning.

Advance ZincTek Limited Announces Director’s Share Acquisition

Advance ZincTek Limited announced a change in the director’s interest, with Lev Mizikovsky acquiring 706 additional ordinary shares through an on-market trade. This change reflects a slight increase in Mizikovsky’s direct holdings, indicating continued confidence in the company’s prospects, which may reassure stakeholders about the company’s stability and future growth potential.

Advance ZincTek Director Increases Shareholding

Advance ZincTek Limited reported a change in the director’s interest, with Lev Mizikovsky acquiring an additional 3,294 ordinary shares through an on-market trade. This change reflects a slight increase in the director’s direct holdings, potentially indicating confidence in the company’s future prospects.

Advance ZincTek Projects $2.7 Million Profit Turnaround Amid Strategic Shifts

Advance ZincTek Limited has announced a significant financial turnaround, expecting a profit before tax of approximately $1.75 million for FY25, compared to a loss of $990,000 in FY24. This improvement is attributed to increased sales in the USA and the closure of the Perth facilities, despite some negative impacts from non-recurring expenses and the loss of a major customer. The company remains debt-free with cash reserves of $767,095 and is exploring capital management initiatives. Product trials for high purity White Sapphire are set to begin, marking a strategic focus on expanding their market presence.